Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Blood Flow Restriction Training in Tennis Elbow (tennis elbow)

14. juli 2026 opdateret af: SAMİ KÜÇÜKŞEN, Necmettin Erbakan University

Effects of Blood Flow Restriction Training on Pain, Function, Disability, Quality of Life, and Common Extensor Tendon Thickness and Echogenicity in Patients With Lateral Epicondylitis: A Prospective Randomized Controlled Trial

Lateral epicondylitis (LE) is a common musculoskeletal disorder caused by repetitive overuse of the forearm extensor muscles. It is characterized by pain over the lateral epicondyle of the humerus, which may radiate to the surrounding tissues at the origin of the wrist extensor tendons. LE is one of the most frequent causes of lateral elbow pain, with a reported prevalence of approximately 1-3% in the general population.

Among conservative interventions, exercise-based rehabilitation is considered a cornerstone of management. In particular, exercise programs incorporating eccentric contractions have demonstrated superior clinical outcomes compared with several other exercise approaches and are therefore widely recommended.

Blood flow restriction training (BFRT) has recently emerged as an alternative rehabilitation strategy that promotes neuromuscular adaptations while using low mechanical loads. BFRT involves the application of a pneumatic cuff, tourniquet, or elastic band around the proximal portion of an extremity to partially restrict arterial inflow while substantially reducing venous return, thereby creating localized metabolic and hemodynamic stress during exercise.

The primary aim of this randomized controlled trial was to investigate the effects of BFRT on pain, functional status, pain-free grip strength, health-related quality of life, and ultrasonographic characteristics of the common extensor tendon in patients with lateral epicondylitis.

Studieoversigt

Detaljeret beskrivelse

Lateral epicondylitis (LE) is a common musculoskeletal disorder caused by repetitive overuse of the forearm extensor muscles. It is characterized by pain over the lateral epicondyle of the humerus, which may radiate to the surrounding tissues at the origin of the wrist extensor tendons. LE is one of the most frequent causes of lateral elbow pain, with a reported prevalence of approximately 1-3% in the general population. Although numerous conservative and invasive treatment modalities have been described, no universally accepted treatment algorithm currently exists. Among conservative interventions, exercise-based rehabilitation is considered a cornerstone of management because it improves tendon load tolerance, increases muscle strength, and facilitates functional recovery.

Although no consensus has been reached regarding the optimal exercise protocol, recent research has focused on interventions that enhance the adaptation of the common extensor tendon to mechanical loading. In particular, exercise programs incorporating eccentric contractions have demonstrated superior clinical outcomes compared with several other exercise approaches and are therefore widely recommended. Furthermore, regular exercise has been shown to improve tendon mechanical properties by increasing collagen synthesis as well as collagen fiber number and diameter.

To achieve meaningful improvements in muscle strength and hypertrophy, resistance exercise is generally recommended at loads of at least 70% of the one-repetition maximum (1RM). However, such loading is often poorly tolerated by individuals experiencing pain, muscle weakness, or muscle atrophy during the early stages of musculoskeletal rehabilitation. Consequently, high-intensity resistance exercise may exacerbate symptoms and reduce treatment adherence.

Blood flow restriction training (BFRT) has recently emerged as an alternative rehabilitation strategy that promotes neuromuscular adaptations while using low mechanical loads. BFRT involves the application of a pneumatic cuff, tourniquet, or elastic band around the proximal portion of an extremity to partially restrict arterial inflow while substantially reducing venous return, thereby creating localized metabolic and hemodynamic stress during exercise.

In BFRT, resistance exercises are typically performed at 20-30% of the one-repetition maximum (1RM). Despite the low training intensity, accumulating evidence indicates that BFRT can produce gains in muscle strength and hypertrophy comparable to those achieved with conventional high-intensity resistance training.

These characteristics make BFRT an attractive adjunct or alternative to traditional resistance exercise in musculoskeletal rehabilitation, particularly for minimizing excessive tissue loading during tendon healing, preventing muscle atrophy, and preserving functional capacity. Nevertheless, evidence regarding the effects of BFRT on clinical outcomes and tendon morphology in patients with lateral epicondylitis remains limited.

The primary aim of this randomized controlled trial was to investigate the effects of BFRT on pain, functional status, pain-free grip strength, health-related quality of life, and ultrasonographic characteristics of the common extensor tendon in patients with lateral epicondylitis. A secondary aim was to compare these outcomes with those achieved using a conventional exercise program and to determine whether BFRT induces measurable structural changes in tendon morphology as assessed by ultrasonography.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

60

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Konya, Tyrkiet (Türkiye)
        • Necmettin Erbakan University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • age between 18 and 75 years;
  • clinical diagnosis of lateral epicondylitis based on medical history and physical examination;
  • pain intensity of ≥4 on a 10-cm Visual Analog Scale (VAS) during daily activities;
  • provision of written informed consent.

Exclusion Criteria:

  • hypertension, diabetes mellitus, cardiovascular disease, peripheral vascular disease, previous deep vein thrombosis, or lymphedema;
  • orthopedic, rheumatologic, or neurological disorders affecting the upper extremity;
  • fibromyalgia;
  • congenital or acquired elbow deformity;
  • previous trauma, fracture, or surgery involving the affected upper extremity;
  • cervical radiculopathy or peripheral neuropathy affecting the involved limb;
  • receipt of any treatment for lateral epicondylitis within the preceding 3 months;
  • skin lesions, infection, or open wounds at the cuff application site;
  • bleeding disorders or current anticoagulant therapy;
  • pregnancy;
  • active malignancy or a history of malignancy;
  • cognitive impairment or neurological or psychiatric disorders that could interfere with comprehension of study procedures or completion of outcome assessments.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Kontrolgruppe
Participants in the control group performed the identical exercise protocol without blood flow restriction.
Eksperimentel: Blood flow restriction training (BFRT) group

Both groups participated in a supervised exercise program consisting of 12 sessions over four weeks (three sessions per week), with each session lasting approximately 45 minutes. Each treatment session began with 3-5 minutes of transverse friction massage applied to the painful region, followed by gentle circular soft-tissue mobilization in a proximal-to-distal direction. Resistance exercises were then performed using dumbbells and consisted of concentric and eccentric wrist extension and forearm supination exercises. The order of exercises was standardized for all participants throughout the intervention period.

Participants allocated to the BFRT group performed the exercise program under blood flow restriction using a pneumatic cuff positioned around the proximal portion of the affected upper arm. Before the intervention, arterial occlusion pressure (AOP) was individually determined for each participant. The cuff pressure used during training was set at 50% of the individual AOP. Tot

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Patient-Rated Tennis Elbow Evaluation (PRTEE)
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a disease-specific, patient-reported outcome measure designed to assess pain and functional disability associated with lateral epicondylitis (14,15). The questionnaire consists of two domains evaluating pain and functional limitations, with a total score ranging from 0 to 100, where higher scores indicate greater pain and disability. The Turkish version of the PRTEE has demonstrated satisfactory validity and reliability
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Visual Analog Scale (VAS)
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Pain intensity at rest and during activity was assessed using a 10-cm Visual Analog Scale (VAS). The scale ranges from 0 ("no pain") to 10 ("worst imaginable pain"). Participants were instructed to indicate the intensity of their pain by marking a point on the scale corresponding to their perceived pain level. The score was determined by measuring the distance (cm) from the left endpoint to the participant's mark. The VAS is a valid and reliable instrument for assessing pain intensity in patients with musculoskeletal disorders.
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Pain-free grip strength (PFGS) Assessment
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
PFGS is considered a sensitive indicator of functional impairment in patients with lateral epicondylitis. Participants were seated with the shoulder in a neutral position, the elbow comfortably extended, and the forearm pronated. Firstly, maximal grip strength was measured using a Jamar hydraulic hand dynamometer in kilograms on the unaffected side. Participants were then instructed to gradually squeeze the dynamometer with the affected hand and stop immediately when pain was first perceived. Three measurements were obtained for each assessment with a 20-second rest interval between trials, and the mean value was used for analysis. PFGS was calculated as the ratio of pain-free grip strength of the affected side to maximal grip strength of the unaffected side. This method has been shown to provide excellent reliability in individuals with lateral epicondylitis.
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Health-Related Quality of Life
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Health-related quality of life was evaluated using the 36-Item Short Form Health Survey (SF-36). The SF-36 comprises eight domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality, social functioning, role limitations due to emotional problems, and mental health. Each domain is scored from 0 to 100, with higher scores indicating better health-related quality of life. The Turkish version of the SF-36 has been validated and shown to be reliable
Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).
Ultrasonographic Evaluation of the Common Extensor Tendon
Tidsramme: Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).

Ultrasonographic examinations were performed using a 7-12 MHz linear-array transducer (Logiq P8; GE Healthcare, Wisconsin, USA). The measurements were taken by a researcher with four years of experience in musculoskeletal ultrasound who did not know which group the patients belonged to.

Participants were examined in a seated position with the elbow flexed to 90° and the forearm pronated. Longitudinal images of the common extensor tendon were obtained, and tendon thickness perpendicular to the tendon fibers, was measured at two standardized anatomical landmarks: (1) the deepest point over the capitellum and (2) the midpoint of the radiocapitellar joint. To improve measurement reliability, each measurement was repeated three times, and the mean value was used for statistical analyses.

Baseline, at 4 weeks (end of intervention), and at 12 weeks (follow-up).

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

28. februar 2025

Primær færdiggørelse (Faktiske)

28. februar 2026

Studieafslutning (Faktiske)

28. februar 2026

Datoer for studieregistrering

Først indsendt

14. juli 2026

Først indsendt, der opfyldte QC-kriterier

14. juli 2026

Først opslået (Faktiske)

17. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

17. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

14. juli 2026

Sidst verificeret

1. maj 2025

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

All collected IPD, all IPD that underlie results in a publication

IPD-delingstidsramme

Starting 6 months after publication- ending 2 years after the publication of results

IPD-delingsadgangskriterier

Journal editors or reviewers may request this information from the corresponding author's email address if they deem it necessary.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Tennisalbue syndrom

Kliniske forsøg med Blood Flow Restriction Training

3
Abonner